A study on combination of Paxil Tablet and benzodiazepines
Not Applicable
- Conditions
- Depression
- Registration Number
- JPRN-jRCT1080220053
- Lead Sponsor
- GlaxoSmithKline K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Main Inclusion criteria-
.Male or Female patients
.>=18 to <65 years old
.Patients with depression or depressive episodes who are diagnosed to have major depressive disorders.
.Patients with 14 or higher points in total scores for Items No.1 - 17 on HAM-D
.Patients who have continuously received Benzodiazepine anxiolytics
-Main Exclusion criteria-
.Patients with a strong suicide tendency
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary endpoint is the extent and rate of decrease in HAM-D total score
- Secondary Outcome Measures
Name Time Method